Tag
Sumitomo Chemical Co., Ltd
2 articles
Sumitomo Pharma Revenue Misstatement Claim ¥165bn
Gotham City Research alleges Sumitomo Pharmaceutical misstated FY2025 revenue by up to ¥165 billion, linked to a ¥48 billion dividend from Swiss subsidiary SMPS.
The report claims the dividend was rec
Sumitomo Chemical Falls 3.6% After Short‑Seller Report
Sumitomo Chemical shares declined 3.6% to ¥494.1, opening at ¥499 and hitting ¥491.3 intraday.
The drop follows Gotham City Research’s August 3 report accusing subsidiary Sumitomo Pharma of misstating